Home›Companies›Biotech & Pharma›Suono Bio

Suono Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 28, 2023·Suggest an edit

About Suono Bio

Suono Bio is a private company based in Foxborough, Massachusetts. It has reported $13,976,840 raised in three offerings on Form D since June 2017. Its chief executive is Scott Kellogg.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 25, 2023Aug 28, 2023$500,000of $3.0M target1$500KDebt, OptionsRule 506(b)Form D ↗
Mar 19, 2021Mar 25, 2021amended Jul 7, 2021$12,176,840of $15.2M target11$1.1MEquityRule 506(b)Form D/A ↗1 earlier filing
Jun 20, 2017Jun 23, 2017$1,300,000of $2.0M target2$650KDebtRule 506(b)Form D ↗
Total, three offerings$13,976,840

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Suono Bio's Form D filed Aug 28, 2023.

CS
Carl Schoellhammer
Executive officer and director
FS
VW
SK
Scott Kellogg
CEO and director
RL

Earlier filings also listed Amy Schulman (director, last listed Jun 2017).

Sources

  1. SECSuono Bio, Inc. Form D, filed Mar 25, 2021
  2. SECSuono Bio, Inc. filing history